Core Points - The Eurasian Economic Union (EAEU) member states have agreed to exempt tariffs on electric vehicles imported to Armenia, Belarus, and Kyrgyzstan starting in 2026 [1] - The tariff exemption has specific limitations on vehicle types and import quantities, with Belarus allowed to import up to 20,000 tariff-exempt pure electric vehicles, while Armenia and Kyrgyzstan can import 15,000 pure electric or hybrid vehicles each [1] - The EAEU Trade Minister, Andrei Slepnev, noted that the tariff exemption measures have shown positive effects during their initial implementation and are expected to continue promoting the electric vehicle market and charging infrastructure development within the EAEU [1] Summary by Category Tariff Exemption Details - Tariff exemptions will apply only to citizens permanently residing in Armenia, Belarus, and Kyrgyzstan [1] - There are restrictions on transferring vehicles to citizens or residents of Kazakhstan and Russia [1] - Azerbaijan and Kyrgyzstan's tariff-exempt hybrid vehicles cannot be transferred to residents of Belarus [1]

Core Points - The U.S. has agreed to remove Section 232 tariffs on pharmaceutical goods from the U.K. as part of a new agreement [1] - The deal includes U.K.-based pharmaceuticals, pharmaceutical ingredients, and medical technology, with no future targeting of U.K. pricing practices during Trump's term [2] - The tariff exemption is contingent upon the U.K. reversing declining National Health Service expenditures on medicines and increasing the net price paid for new medicines by 25% [3] - This announcement is part of the U.S.-U.K. Economic Prosperity Deal framework, which aims to address tariffs and market access, with the potential for the U.K. to reduce tariffs on U.S. goods from 5.1% to 1.8% [4] - Trump has been focusing on pharmaceutical imports as part of a sector-specific tariff strategy, with a Section 232 investigation initiated in April [5] - Plans for a 100% sector-specific tariff on branded or patented pharmaceutical products were announced in September, alongside a probe into healthcare-related products [6]

Group 1 - Vita Coco's stock surged over 10% following the announcement of eligibility for tariff exemptions on agricultural products [1] - The executive order signed by President Trump removed tariffs on products that cannot be grown in the U.S., benefiting companies like Vita Coco [1] - Hershey received an upgrade in its Relative Strength (RS) rating, indicating improved price performance, while Vita Coco also saw a rise in its RS rating to 83 [4] Group 2 - Celsius stock reached a new buy point before experiencing a retreat, with third-quarter earnings results expected in early November [2]

Core Insights - The U.S.-Mexico-Canada Agreement (USMCA) is under review, prompting manufacturers to consider strategies to minimize tariff exposure [1][5] - Cross-border trade has been affected by the transition from NAFTA to USMCA and the imposition of tariffs, with significant duties on non-compliant imports [2][3] - Companies are reassessing their compliance with USMCA to leverage tariff exemptions, which has led to competitive advantages for some [3][6] Trade Dynamics - The U.S. imports $505.5 billion from Mexico and $411.9 billion from Canada in 2024, making them its largest trading partners [3] - Tariff exemptions have encouraged firms to evaluate their products for compliance, although the overall tariff situation remains uncertain [2][4] Manufacturing Strategies - Manufacturers with global supply chains are hesitant to make significant changes due to the fluid tariff situation and upcoming USMCA review [4][5] - Some companies are exploring shifting manufacturing to Mexico, but there has not been a significant resurgence in U.S. manufacturing interest [4][5] Compliance Benefits - Companies already compliant with USMCA are experiencing reduced costs and gaining market advantages [6] - Methode Electronics and Newell Brands have reported increased business due to their USMCA-compliant operations, allowing them to avoid tariffs [7]

If you're waiting for delivery from UPS, the package you've been expecting may have been disposed of. UPS is telling customers, UPS customers rather, are telling us, NBC News, that their packages, including things like tea and telescopes, luxury glassware, musical instruments, even more than that, some worth tens of thousands of dollars. Those packages are stuck in customs purgatory, or maybe even gone.It's happening because a longstanding tariff exemption on low value packages ended back in August and that ...

Group 1: Downgrades and Price Targets - BofA Global Research downgraded United Parcel Service Inc (UPS) to "underperform" from "neutral" and FedEx Corp (FDX) to "neutral" from "buy" [1] - The price target for UPS was cut to $83 from $91, while FDX's price objective was lowered to $240 from $245 [1] Group 2: Stock Performance and Market Trends - UPS was last seen at $84.06, having previously slipped to a five-year low of $82, with a 33.2% deficit projected for 2025 [2] - FDX was last seen trading at $229.82, with support at the $220 region, but has an 18.34% year-to-date deficit [4] Group 3: Options Trading Activity - UPS's 10-day call/put volume ratio of 6.03 indicates that options traders are more bullish than usual, ranking higher than 94% of annual readings [3] - For FDX, options traders have traded 3,805 puts, which is triple the intraday average, compared to 1,781 calls, with the most popular contract being the weekly 9/12 220-strike put [4]